The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica Cell Technologies, Inc.
SAN DIEGO, Sept. 7 /PRNewswire/ -- Stemedica Cell Technologies, Inc.,
("Stemedica"), a world leader in stem cell research and manufacturing,
announced the signing of an agreement today for its breakthrough stem cell and
related technology. The Jordanian Stem Cell Company has signed a five year
multi-million dollar agreement to purchase the technology from Stemedica's
wholly-owned subsidiary, Stemedica International, S.A. The signing ceremony
took place at the European Burns Association Congress in Lausanne,
Switzerland.